Spero Therapeutics, Inc. (SPRO) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Spero Therapeutics, Inc. (SPRO) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

SPRO Cash Flow Statement

Spero Therapeutics, Inc. (SPRO) cash flow statement — 11-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-5.36M	15.86M	-8.35M	17.42M	-17.69M	-4M	-23.4M	12.76M	-18.74M	5.94M	-17.49M	15.91M	-18.56M	-12.85M	44.48M	-957K	-23.03M	-28.22M	-27.35M	-4.95M
Operating CF Margin %	-	6148.84%	-21.06%	571.59%	-149.92%	-68.13%	-155.55%	94.76%	-183.82%	141.25%	-23.79%	62.48%	-683.51%	-621.22%	95.96%	-88.45%	-2570.65%	-11426.32%	-996.68%	-699.43%
Operating CF Growth %	69.73%	496.4%	64.31%	36.5%	5.61%	-167.4%	-33.77%	-19.81%	-0.97%	146.2%	-139.33%	1763.01%	19.4%	54.46%	262.65%	80.67%	-39.03%	-82.33%	-66.94%	76.71%
Net Income	-9.55M	-7.2M	31.52M	-7.38M	-1.7M	-13.87M	-20.89M	-17.15M	-17.86M	-12.67M	51.19M	-3.21M	-11.91M	-13.27M	26.77M	-11.68M	-28.68M	-32.83M	-29.24M	-22.52M
Depreciation & Amortization	0	0	0	0	0	0	0	0	2K	0	38K	108K	108K	113K	129K	257K	291K	189K	191K	148K
Stock-Based Compensation	0	1.11M	1.01M	1.05M	714K	1.56M	1.5M	2.15M	2.11M	2.02M	2M	1.91M	1.86M	2.17M	2.5M	2.11M	0	3.2M	2.93M	2.33M
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-154K	0
Other Non-Cash Items	1.05M	226K	214K	870K	278K	273K	268K	263K	258K	254K	249K	5.55M	240K	236K	93K	890K	4.03M	2.9M	1.76M	308K
Working Capital Changes	3.15M	21.73M	-41.09M	22.89M	-16.98M	8.04M	-4.28M	27.49M	-3.25M	16.33M	-70.97M	11.55M	-8.86M	-2.11M	14.99M	7.46M	1.33M	-1.69M	-2.83M	14.78M
Change in Receivables	19K	-16K	1.56M	869K	-1.79M	2.42M	-389K	2.04M	283K	-3.47M	1.44M	-901K	-223K	-781K	-131K	624K	393K	0	0	-394K
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	131K	0	0	0	0	0
Change in Payables	-62K	-476K	-702K	615K	-985K	-5.54M	1.22M	3.39M	-370K	1.69M	275K	-207K	727K	-34K	-1.97M	871K	-3.07M	3.68M	-2.06M	1.53M
Cash from Investing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	33.94M	-129K	50M	-16.06M	-23.27M	17.02M
Capital Expenditures	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-129K	0	0	0	39K	0
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.28%	-	-	-	1.42%	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	258K	-129K	0	0	0	0
Cash from Financing	0	0	0	0	0	0	0	0	0	0	1K	220K	0	0	14.18M	6.13M	-53.68M	3.81M	50.35M	29.22M
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-54.48M	0	0	0
Equity Issued (Net)	0	0	0	0	0	0	0	0	0	0	1K	220K	0	0	14.18M	6.13M	808K	3.63M	2.47M	28.64M
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1K	0	0	188K	47.88M	583K
Net Change in Cash	-5.36M	15.86M	-8.35M	17.42M	-17.69M	-4M	-23.4M	12.76M	-18.74M	5.94M	-17.49M	16.14M	-18.56M	-12.85M	58.66M	5.04M	-26.71M	-40.47M	-275K	41.3M
Free Cash Flow	-5.36M	15.86M	-8.35M	17.42M	-17.69M	-4M	-23.4M	12.76M	-18.74M	5.94M	-17.49M	15.91M	-18.56M	-12.85M	44.35M	-957K	-23.03M	-28.22M	-27.31M	-4.95M
FCF Margin %	-	6148.84%	-21.06%	571.59%	-149.92%	-68.13%	-155.55%	94.76%	-183.82%	141.25%	-23.79%	62.48%	-683.51%	-621.22%	95.68%	-88.45%	-2570.65%	-11426.32%	-995.26%	-699.43%
FCF Growth %	69.73%	496.4%	64.31%	36.5%	5.61%	-167.4%	-33.77%	-19.81%	-0.97%	146.2%	-139.44%	1763.01%	19.4%	54.46%	262.41%	80.67%	-39.03%	-82.33%	-66.58%	76.77%
FCF per Share	-0.09	0.28	-0.14	0.31	-0.32	-0.07	-0.43	0.24	-0.35	0.11	-0.33	0.30	-0.35	-0.24	0.91	-0.03	-0.70	-0.87	-0.85	-0.15
FCF Conversion (FCF/Net Income)	0.56x	-2.20x	-0.26x	-2.36x	10.41x	0.29x	1.12x	-0.74x	1.05x	-0.47x	-0.34x	-4.97x	1.56x	0.97x	1.66x	0.08x	0.80x	0.86x	0.94x	0.22x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0